Publications
Filters: Author is Webster, S P [Clear All Filters]
11-Beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors in type 2 diabetes mellitus and obesity. Expert Opin Investig Drugs. 2008;17(4):481-96. Abstract
Antidiabetic activity of N-(6-substituted-1,3-benzothiazol-2-yl)benzenesulfonamides. Bioorganic & medicinal chemistry letters. 2008;18:2871-7. Abstract
Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes, obesity & metabolism. 2008;10:1097-104. Abstract
Discovery and biological evaluation of adamantyl amide 11beta-HSD1 inhibitors. Bioorganic & medicinal chemistry letters. 2007;17:2838-43. Abstract
Modulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-tetrazoles. Bioorg Med Chem Lett. 2010;20(11):3265-71. Abstract
Partial deficiency or short-term inhibition of 11beta-hydroxysteroid dehydrogenase type 1 improves cognitive function in aging mice. J Neurosci. 2010;30(41):13867-72. Abstract
Suicide inhibition of alpha-oxamine synthases: structures of the covalent adducts of 8-amino-7-oxononanoate synthase with trifluoroalanine. Organic & biomolecular chemistry. 2006;4:1209-12. Abstract


]